Review
Copyright ©The Author(s) 2020.
World J Transplant. Sep 18, 2020; 10(9): 230-255
Published online Sep 18, 2020. doi: 10.5500/wjt.v10.i9.230
Table 2 Summary of micro-ribonucleic acid-related novel biomarker studies associated with immunologic outcomes
Ref.nSampleBiomarkersOutcomeStudy conclusion
Matz et al[17], 2016160PlasmamiR-15B, miR-103A, miR-106ATCMRmiR-15Ba,b, miR-103Aa,b and miR-106Aa,b discriminated patients with stable graft function from patients with TCMR and UTI
Matz et al[18], 2018111PlasmamiR-223-3p; miR-424-3p; miR-145-5p; miR-15b-5pABMR, TCMR, IFTAmiR-223-3p, miR-424-3p and miR-145-5p distinguished TCMR and ABMR from stable graft function; mir-145-5P decreased in IFTA (AUC 0.891) compared to stable graft function
Millán et al[19], 201780UrinemiR-142-3p, miR-210-3p and miR-155-5p, CXCL10Rejection↑miR-142-3p, ↑miR-155-5p, ↑CXCL10 + ↓miR-210-3p (AUC = 0.875) and CXCL10 (AUC = 0.865) discriminate rejectors and nonrejectors (sensitivity 85%, 84% and specificity 86% and 80% respectively)
Halloran et al[20], 2017519Allograft biopsyMolecular Microscope® Diagnostic System (MMDx™)/microRNATCMR, ABMRAgreement between MMDx™ and histology = 77% for TCMR, 77% for ABMR, and 76% for no rejection with blinding to histology, HLA. MMDx™c agreed with clinical judgment (87%) more than histology (80%)
Ledeganck et al[21], 201911 studiesAllograft biopsymicroRNATCMR, ABMR, cABMR↑miR-142, miR-155, miR-223 and ↓miR-125, miR-30, miR-204 predict TCMR, ABMR, cABMR
Lorenzen et al[23], 201593UrinelcRNA; RP11-354P17.15-001 (L328)TCMRRP11-354P17.15-001d (L328) was associated with acute TCMR (AUC = 0.76) sensitivity 49%, specificity 95%; L328 can detect subclinical TCMR